Global Hemophilia A Drug Market Professional Survey Report 2018

January 2018 | 110 pages | ID: G37BB6C9BC0EN
QYResearch

Abstracts

This report studies Hemophilia A Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Bayer AG
• BioMarin Pharmaceutical Inc
• Bioverativ Inc
• Catalyst Biosciences Inc
• Chugai Pharmaceutical Co Ltd
• CSL Ltd
• DBV Technologies SA
• Dimension Therapeutics Inc
• EpiVax Inc
• Expression Therapeutics LLC
• Green Cross Corp
• Idogen AB
• Immusoft Corp
• LFB SA
• mAbxience SA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• ATXF-8117
• BAY-1093884
• BIVV-001
• BS-027125
• Concizumab
• CSL-689
• Others

By Application, the market can be split into

• Clinic
• Hospital
• ASCs

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Hemophilia A Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF HEMOPHILIA A DRUG

1.1 Definition and Specifications of Hemophilia A Drug
  1.1.1 Definition of Hemophilia A Drug
  1.1.2 Specifications of Hemophilia A Drug
1.2 Classification of Hemophilia A Drug
  1.2.1 ATXF-8117
  1.2.2 BAY-1093884
  1.2.3 BIVV-001
  1.2.4 BS-027125
  1.2.5 Concizumab
  1.2.6 CSL-689
  1.2.7 Others
1.3 Applications of Hemophilia A Drug
  1.3.1 Clinic
  1.3.2 Hospital
  1.3.3 ASCs
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF HEMOPHILIA A DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hemophilia A Drug
2.3 Manufacturing Process Analysis of Hemophilia A Drug
2.4 Industry Chain Structure of Hemophilia A Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF HEMOPHILIA A DRUG

3.1 Capacity and Commercial Production Date of Global Hemophilia A Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Hemophilia A Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Hemophilia A Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Hemophilia A Drug Major Manufacturers in 2016

4 GLOBAL HEMOPHILIA A DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Hemophilia A Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Hemophilia A Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Hemophilia A Drug Sales and Growth Rate Analysis
  4.3.2 2016 Hemophilia A Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Hemophilia A Drug Sales Price
  4.4.2 2016 Hemophilia A Drug Sales Price Analysis (Company Segment)

5 HEMOPHILIA A DRUG REGIONAL MARKET ANALYSIS

5.1 North America Hemophilia A Drug Market Analysis
  5.1.1 North America Hemophilia A Drug Market Overview
  5.1.2 North America 2012-2017E Hemophilia A Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Hemophilia A Drug Sales Price Analysis
  5.1.4 North America 2016 Hemophilia A Drug Market Share Analysis
5.2 China Hemophilia A Drug Market Analysis
  5.2.1 China Hemophilia A Drug Market Overview
  5.2.2 China 2012-2017E Hemophilia A Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Hemophilia A Drug Sales Price Analysis
  5.2.4 China 2016 Hemophilia A Drug Market Share Analysis
5.3 Europe Hemophilia A Drug Market Analysis
  5.3.1 Europe Hemophilia A Drug Market Overview
  5.3.2 Europe 2012-2017E Hemophilia A Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Hemophilia A Drug Sales Price Analysis
  5.3.4 Europe 2016 Hemophilia A Drug Market Share Analysis
5.4 Southeast Asia Hemophilia A Drug Market Analysis
  5.4.1 Southeast Asia Hemophilia A Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Hemophilia A Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Hemophilia A Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Hemophilia A Drug Market Share Analysis
5.5 Japan Hemophilia A Drug Market Analysis
  5.5.1 Japan Hemophilia A Drug Market Overview
  5.5.2 Japan 2012-2017E Hemophilia A Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Hemophilia A Drug Sales Price Analysis
  5.5.4 Japan 2016 Hemophilia A Drug Market Share Analysis
5.6 India Hemophilia A Drug Market Analysis
  5.6.1 India Hemophilia A Drug Market Overview
  5.6.2 India 2012-2017E Hemophilia A Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Hemophilia A Drug Sales Price Analysis
  5.6.4 India 2016 Hemophilia A Drug Market Share Analysis

6 GLOBAL 2012-2017E HEMOPHILIA A DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Hemophilia A Drug Sales by Type
6.2 Different Types of Hemophilia A Drug Product Interview Price Analysis
6.3 Different Types of Hemophilia A Drug Product Driving Factors Analysis
  6.3.1 ATXF-8117 of Hemophilia A Drug Growth Driving Factor Analysis
  6.3.2 BAY-1093884 of Hemophilia A Drug Growth Driving Factor Analysis
  6.3.3 BIVV-001 of Hemophilia A Drug Growth Driving Factor Analysis
  6.3.4 BS-027125 of Hemophilia A Drug Growth Driving Factor Analysis
  6.3.5 Concizumab of Hemophilia A Drug Growth Driving Factor Analysis
  6.3.6 CSL-689 of Hemophilia A Drug Growth Driving Factor Analysis
  6.3.7 Others of Hemophilia A Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E HEMOPHILIA A DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Hemophilia A Drug Consumption by Application
7.2 Different Application of Hemophilia A Drug Product Interview Price Analysis
7.3 Different Application of Hemophilia A Drug Product Driving Factors Analysis
  7.3.1 Clinic of Hemophilia A Drug Growth Driving Factor Analysis
  7.3.2 Hospital of Hemophilia A Drug Growth Driving Factor Analysis
  7.3.3 ASCs of Hemophilia A Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF HEMOPHILIA A DRUG

8.1 Bayer AG
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Bayer AG 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Bayer AG 2016 Hemophilia A Drug Business Region Distribution Analysis
8.2 BioMarin Pharmaceutical Inc
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 BioMarin Pharmaceutical Inc 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 BioMarin Pharmaceutical Inc 2016 Hemophilia A Drug Business Region Distribution Analysis
8.3 Bioverativ Inc
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Bioverativ Inc 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Bioverativ Inc 2016 Hemophilia A Drug Business Region Distribution Analysis
8.4 Catalyst Biosciences Inc
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Catalyst Biosciences Inc 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Catalyst Biosciences Inc 2016 Hemophilia A Drug Business Region Distribution Analysis
8.5 Chugai Pharmaceutical Co Ltd
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Chugai Pharmaceutical Co Ltd 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Chugai Pharmaceutical Co Ltd 2016 Hemophilia A Drug Business Region Distribution Analysis
8.6 CSL Ltd
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 CSL Ltd 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 CSL Ltd 2016 Hemophilia A Drug Business Region Distribution Analysis
8.7 DBV Technologies SA
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 DBV Technologies SA 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 DBV Technologies SA 2016 Hemophilia A Drug Business Region Distribution Analysis
8.8 Dimension Therapeutics Inc
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Dimension Therapeutics Inc 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Dimension Therapeutics Inc 2016 Hemophilia A Drug Business Region Distribution Analysis
8.9 EpiVax Inc
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 EpiVax Inc 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 EpiVax Inc 2016 Hemophilia A Drug Business Region Distribution Analysis
8.10 Expression Therapeutics LLC
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Expression Therapeutics LLC 2016 Hemophilia A Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Expression Therapeutics LLC 2016 Hemophilia A Drug Business Region Distribution Analysis
8.11 Green Cross Corp
8.12 Idogen AB
8.13 Immusoft Corp
8.14 LFB SA
8.15 mAbxience SA

9 DEVELOPMENT TREND OF ANALYSIS OF HEMOPHILIA A DRUG MARKET

9.1 Global Hemophilia A Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Hemophilia A Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Hemophilia A Drug Sales Price Forecast
9.2 Hemophilia A Drug Regional Market Trend
  9.2.1 North America 2017-2022 Hemophilia A Drug Consumption Forecast
  9.2.2 China 2017-2022 Hemophilia A Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Hemophilia A Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Hemophilia A Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Hemophilia A Drug Consumption Forecast
  9.2.6 India 2017-2022 Hemophilia A Drug Consumption Forecast
9.3 Hemophilia A Drug Market Trend (Product Type)
9.4 Hemophilia A Drug Market Trend (Application)

10 HEMOPHILIA A DRUG MARKETING TYPE ANALYSIS

10.1 Hemophilia A Drug Regional Marketing Type Analysis
10.2 Hemophilia A Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hemophilia A Drug by Region
10.4 Hemophilia A Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF HEMOPHILIA A DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL HEMOPHILIA A DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia A Drug
Table Product Specifications of Hemophilia A Drug
Table Classification of Hemophilia A Drug
Figure Global Production Market Share of Hemophilia A Drug by Type in 2016
Figure ATXF-8117 Picture
Table Major Manufacturers of ATXF-8117
Figure BAY-1093884 Picture
Table Major Manufacturers of BAY-1093884
Figure BIVV-001 Picture
Table Major Manufacturers of BIVV-001
Figure BS-027125 Picture
Table Major Manufacturers of BS-027125
Figure Concizumab Picture
Table Major Manufacturers of Concizumab
Figure CSL-689 Picture
Table Major Manufacturers of CSL-689
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Hemophilia A Drug
Figure Global Consumption Volume Market Share of Hemophilia A Drug by Application in 2016
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Hospital Examples
Table Major Consumers in Hospital
Figure ASCs Examples
Table Major Consumers in ASCs
Figure Market Share of Hemophilia A Drug by Regions
Figure North America Hemophilia A Drug Market Size (Million USD) (2012-2022)
Figure China Hemophilia A Drug Market Size (Million USD) (2012-2022)
Figure Europe Hemophilia A Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Hemophilia A Drug Market Size (Million USD) (2012-2022)
Figure Japan Hemophilia A Drug Market Size (Million USD) (2012-2022)
Figure India Hemophilia A Drug Market Size (Million USD) (2012-2022)
Table Hemophilia A Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hemophilia A Drug in 2016
Figure Manufacturing Process Analysis of Hemophilia A Drug
Figure Industry Chain Structure of Hemophilia A Drug
Table Capacity and Commercial Production Date of Global Hemophilia A Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Hemophilia A Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Hemophilia A Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Hemophilia A Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Hemophilia A Drug 2012-2017
Figure Global 2012-2017E Hemophilia A Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Hemophilia A Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Hemophilia A Drug Capacity and Growth Rate
Table 2016 Global Hemophilia A Drug Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Hemophilia A Drug Sales (K Pcs) and Growth Rate
Table 2016 Global Hemophilia A Drug Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Hemophilia A Drug Sales Price (USD/Pcs)
Table 2016 Global Hemophilia A Drug Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Hemophilia A Drug 2012-2017E
Figure North America 2012-2017E Hemophilia A Drug Sales Price (USD/Pcs)
Figure North America 2016 Hemophilia A Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Hemophilia A Drug 2012-2017E
Figure China 2012-2017E Hemophilia A Drug Sales Price (USD/Pcs)
Figure China 2016 Hemophilia A Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Hemophilia A Drug 2012-2017E
Figure Europe 2012-2017E Hemophilia A Drug Sales Price (USD/Pcs)
Figure Europe 2016 Hemophilia A Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Hemophilia A Drug 2012-2017E
Figure Southeast Asia 2012-2017E Hemophilia A Drug Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Hemophilia A Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Hemophilia A Drug 2012-2017E
Figure Japan 2012-2017E Hemophilia A Drug Sales Price (USD/Pcs)
Figure Japan 2016 Hemophilia A Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Hemophilia A Drug 2012-2017E
Figure India 2012-2017E Hemophilia A Drug Sales Price (USD/Pcs)
Figure India 2016 Hemophilia A Drug Sales Market Share
Table Global 2012-2017E Hemophilia A Drug Sales (K Pcs) by Type
Table Different Types Hemophilia A Drug Product Interview Price
Table Global 2012-2017E Hemophilia A Drug Sales (K Pcs) by Application
Table Different Application Hemophilia A Drug Product Interview Price
Table Bayer AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer AG Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bayer AG Hemophilia A Drug Business Region Distribution
Table BioMarin Pharmaceutical Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 BioMarin Pharmaceutical Inc Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 BioMarin Pharmaceutical Inc Hemophilia A Drug Business Region Distribution
Table Bioverativ Inc Information List
Table Product A Overview
Table Product B Overview
Table 2015 Bioverativ Inc Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bioverativ Inc Hemophilia A Drug Business Region Distribution
Table Catalyst Biosciences Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Catalyst Biosciences Inc Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Catalyst Biosciences Inc Hemophilia A Drug Business Region Distribution
Table Chugai Pharmaceutical Co Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Business Region Distribution
Table CSL Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 CSL Ltd Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 CSL Ltd Hemophilia A Drug Business Region Distribution
Table DBV Technologies SA Information List
Table Product A Overview
Table Product B Overview
Table 2016 DBV Technologies SA Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 DBV Technologies SA Hemophilia A Drug Business Region Distribution
Table Dimension Therapeutics Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dimension Therapeutics Inc Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Dimension Therapeutics Inc Hemophilia A Drug Business Region Distribution
Table EpiVax Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 EpiVax Inc Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 EpiVax Inc Hemophilia A Drug Business Region Distribution
Table Expression Therapeutics LLC Information List
Table Product A Overview
Table Product B Overview
Table 2016 Expression Therapeutics LLC Hemophilia A Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Expression Therapeutics LLC Hemophilia A Drug Business Region Distribution
Table Green Cross Corp Information List
Table Idogen AB Information List
Table Immusoft Corp Information List
Table LFB SA Information List
Table mAbxience SA Information List
Figure Global 2017-2022 Hemophilia A Drug Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Hemophilia A Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Hemophilia A Drug Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Hemophilia A Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Hemophilia A Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Hemophilia A Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Hemophilia A Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Hemophilia A Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Hemophilia A Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Hemophilia A Drug by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Hemophilia A Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Hemophilia A Drug by Region